Nanotechnology approach for drug addiction therapy: Gene silencing using delivery of gold nanorod-siRNA nanoplex in dopaminergic neurons
- 7 April 2009
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 106 (14), 5546-5550
- https://doi.org/10.1073/pnas.0901715106
Abstract
Ku is a heterodimer of Mr 70,000 and Mr 86,000 subunits. It binds with strong affinity to DNA ends and is indispensable for nonhomologous DNA end joining (NHEJ) and V(D)J recombination. In this study, we investigated whether down-regulation of the Ku86 gene, by 2′-O-methoxyethyl/uniform phosphorothioate chimeric antisense oligonucleotides (ASOs), increases the sensitivity of the DNA-protein kinase catalytic subunit (PKcs)-proficient human glioma cell line (M059K), and its isogenic DNA-PKcs-deficient counterpart (M059J), to ionizing radiation and anticancer drugs. Transfection of these cell lines with 200 nm Ku86 antisense ASOs was associated with a specific decrease in Ku86 mRNA levels (IC50 n = 3) and a concomitant rapid decrease (<10% of control) in Ku86 protein expression. Moreover, transfection of M059K cells with Ku86 antisense ASOs markedly increased cell death after treatment with ionizing radiation, bleomycin, and etoposide. However, no sensitization to the DNA cross-linking agents chlorambucil and cisplatin was observed after Ku86 antisense transfection. As expected, transfection of M059J cells with Ku86 antisense ASOs did not result in any sensitization to ionizing radiation, bleomycin, or DNA cross-linking agents, but there was a 2-fold increase in sensitivity to etoposide. Thus, our results indicate that antisense ASOs targeted against Ku86 may increase the efficacy of radiotherapy and DNA-damaging agents in tumor treatment. Furthermore, Ku86 antisense ASOs may be used to create a temporal knockout in different human cell lines to further investigate the biological roles of Ku86.Keywords
This publication has 34 references indexed in Scilit:
- Methamphetamine alters blood brain barrier permeability via the modulation of tight junction expression: Implication for HIV-1 neuropathogenesis in the context of drug abuseBrain Research, 2008
- Gold Nanorods Coated with Multilayer Polyelectrolyte as Contrast Agents for Multimodal ImagingThe Journal of Physical Chemistry C, 2007
- Interfering with disease: a progress report on siRNA-based therapeuticsNature Reviews Drug Discovery, 2007
- shRNA and siRNA delivery to the brainAdvanced Drug Delivery Reviews, 2007
- Using Gold Nanorods to Probe Cell-Induced Collagen DeformationNano Letters, 2006
- Drogues addictives, protéine phosphatases et voie ERKmédecine/sciences, 2005
- Permeability Studies on In Vitro Blood–Brain Barrier Models: Physiology, Pathology, and PharmacologyCellular and Molecular Neurobiology, 2005
- The role of DARPP-32 in the actions of drugs of abuseNeuropharmacology, 2004
- New approaches to in vitro models of blood–brain barrier drug transportDrug Discovery Today, 2003
- Beyond the Dopamine ReceptorNeuron, 1999